Yuan Da Sai Wei Xin

Grandpharma Savonix, officially known as Wuhan Grandpharma Savonix Biopharmaceutical Co., Ltd., is a Chinese biotechnology company and a subsidiary of China Grand Pharmaceutical and Healthcare Holdings (Grandpharma). The company specializes in the development of innovative vaccines, with a primary focus on infectious diseases. Its lead program is a tetravalent recombinant norovirus vaccine produced using a Pichia pastoris expression system, which has received clinical trial approval in China. Grandpharma Savonix leverages advanced recombinant protein technology to address significant unmet needs in the vaccine market, particularly for pathogens like norovirus that cause widespread outbreaks of acute gastroenteritis.